Dr. Abdul Ahad is an Associate Professor at Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. He has published more than hundred high quality research and review articles in several peer-reviewed journals of international repute.
As per Google Scholar his publication received 2859 citations and his h-index is 31, i10-index 66. One of his patent “A novel formulation to transdermally deliver antihypertensive agent with permeability enhancer”, patent number 277571, granted on 24/11/2016.
Dr. Abdul Ahad has been listed among the world's top 2% SCIENTIST List 2019, prepared by the STANFORD UNIVERSITY, USA. (References: Table S7, Baas, Jeroen; Boyack, Kevin; Ioannidis, John (2020), “Data for "Updated science-wide author databases of standardized citation indicators"”, Mendeley Data, V2, doi: 10.17632/btchxktzyw.2).
He is on Editorial Board of high ranked pharmaceutical peer-reviewed journals.
His current research interest lies in lipid based nanomedicine formulations development for oral/dermal/transdermal drug delivery.
For more information about Dr. Abdul Ahad, see his webpage at https://scholar.google.com/citations?hl=en&user=qKsiOo0AAAAJ as well as visit his ResearchID at http://www.researcherid.com/rid/L-8383-2015.